[go: up one dir, main page]

SV2016005348A - Mã‰todos para tratar infecciones - Google Patents

Mã‰todos para tratar infecciones

Info

Publication number
SV2016005348A
SV2016005348A SV2016005348A SV2016005348A SV2016005348A SV 2016005348 A SV2016005348 A SV 2016005348A SV 2016005348 A SV2016005348 A SV 2016005348A SV 2016005348 A SV2016005348 A SV 2016005348A SV 2016005348 A SV2016005348 A SV 2016005348A
Authority
SV
El Salvador
Prior art keywords
days
approximately
treat infections
approximate
treat
Prior art date
Application number
SV2016005348A
Other languages
English (en)
Inventor
Danping Li
Scott J Hopkins
Jarrod Longcor
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54868662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2016005348(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of SV2016005348A publication Critical patent/SV2016005348A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A MÉTODOS PARA TRATAR, PREVENIR, O REDUCIR EL DE INFECCIONES MICROBIANAS AL MISMO TIEMPO QUE MINIMIZA LOS EFECTOS ADVERSOS GASTROINTESTINALES USANDO UN RÉGIMEN DE DOSIFICACIÓN DE DOS ETAPAS QUE COMPRENDE APROXIMADAMENTE 1 HASTA APROXIMADAMENTE 7 D�AS DE ADMINISTRACIÓN INTRAVENOSA SEGUIDO POR APROXIMADAMENTE 1 HASTA APROXIMADAMENTE 14 D�AS DE ADMINISTRACIÓN ORAL DE UN AGENTE ANTIMICROBIANO
SV2016005348A 2014-06-20 2016-12-20 Mã‰todos para tratar infecciones SV2016005348A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462014790P 2014-06-20 2014-06-20
US201462034468P 2014-08-07 2014-08-07
PCT/US2015/036699 WO2015196076A1 (en) 2014-06-20 2015-06-19 Methods for treating infections

Publications (1)

Publication Number Publication Date
SV2016005348A true SV2016005348A (es) 2017-03-02

Family

ID=54868662

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2016005348A SV2016005348A (es) 2014-06-20 2016-12-20 Mã‰todos para tratar infecciones

Country Status (17)

Country Link
US (2) US20150366858A1 (es)
EP (1) EP3157633A4 (es)
JP (1) JP2017518354A (es)
CN (1) CN106687179A (es)
AU (1) AU2015276911A1 (es)
BR (1) BR112016029896A2 (es)
CA (1) CA2952955A1 (es)
CL (1) CL2016003271A1 (es)
EA (1) EA201692531A1 (es)
EC (1) ECSP16095557A (es)
IL (1) IL249616A0 (es)
MX (1) MX2016017348A (es)
PH (1) PH12016502547A1 (es)
SV (1) SV2016005348A (es)
TW (1) TW201605447A (es)
UY (1) UY36183A (es)
WO (1) WO2015196076A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105693695A (zh) * 2014-11-24 2016-06-22 重庆医药工业研究院有限责任公司 一种德拉沙星葡甲胺盐的晶型及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
EP3056492B1 (en) * 2004-10-08 2021-09-22 AbbVie Inc. Meglumine salt and crystalline forms thereof of a drug (delafloxacin)
WO2006110815A1 (en) * 2005-04-11 2006-10-19 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CN1943561A (zh) * 2006-08-23 2007-04-11 北京阜康仁生物制药科技有限公司 普卢利沙星口腔崩解片及其制备方法
CN102164912B (zh) * 2008-09-24 2015-08-19 麦林塔医疗有限公司 制备喹诺酮类化合物的工艺
WO2010056872A2 (en) * 2008-11-15 2010-05-20 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
WO2010096551A2 (en) * 2009-02-18 2010-08-26 Rib-X Pharmaceuticals, Inc. Antimicrobial compositions
BR112015023044A8 (pt) * 2013-03-15 2021-09-28 Melinta Subsidiary Corp Métodos para tratar infecções em pacientes acima do peso e obesos com o uso de antibióticos

Also Published As

Publication number Publication date
PH12016502547A1 (en) 2017-04-10
AU2015276911A1 (en) 2017-01-12
US20150366858A1 (en) 2015-12-24
EP3157633A1 (en) 2017-04-26
US20170368055A1 (en) 2017-12-28
CN106687179A (zh) 2017-05-17
EP3157633A4 (en) 2018-02-21
AU2015276911A2 (en) 2018-04-26
MX2016017348A (es) 2017-04-06
JP2017518354A (ja) 2017-07-06
EA201692531A1 (ru) 2017-05-31
CA2952955A1 (en) 2015-12-23
IL249616A0 (en) 2017-02-28
ECSP16095557A (es) 2017-03-31
TW201605447A (zh) 2016-02-16
UY36183A (es) 2016-01-29
CL2016003271A1 (es) 2017-08-04
BR112016029896A2 (pt) 2017-08-22
WO2015196076A1 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
CY1125205T1 (el) Φαρμακευτικες συνθεσεις δραστικων απο θεραπευτικη αποψη ενωσεων
CL2019000221A1 (es) Compuestos de tiazolo-piridina sustituida como inhibidores de malt1.
UA124347C2 (uk) Циклічна динуклеотидна сполука
MX2019009796A (es) Compuestos para el tratamiento del cancer.
MX2017008720A (es) Derivados y metodos para tratamiento de las infecciones por hepatitis b.
MX2018006503A (es) Compuesto novedoso de bifenilo o una sal del mismo.
GT201700179A (es) Formulaciones en polvo nasal para el tratamiento de hipoglicemia
MX2019014104A (es) Compuesto novedoso de bifenilo o sal del mismo.
CL2019001996A1 (es) Usos terapéuticos de un polvo de insectos.
MX2018010993A (es) Derivados de icariina e icaritina.
BR112019003577A2 (pt) métodos de tratamento da semente e produtos resultantes
MX381776B (es) Formulacion acuosa que comprende paracetamol e ibuprofeno.
MX2017009849A (es) Composiciones de profármaco de monometilfumarato.
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
ECSP19026702A (es) Compuestos novedosos para el tratamiento de enfermedades parasitarias
ECSP20023626A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
BR112016024235A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
NZ757526A (en) Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction
MX383032B (es) Formulaciones farmaceuticas inyectables de lefamulina.
BR112016012036A2 (pt) prevenção da diarréia pela escherichia coli
SV2016005348A (es) Mã‰todos para tratar infecciones
CL2020003153A1 (es) Composiciones antimicrobianas con agentes efervescentes (divisional de solicitud n° 03273-2016)
BR112016024236A2 (pt) composições farmacêuticas compreendendo agentes antibacterianos
CR20160591A (es) Metodos para tratar infecciones
CO2019001967A2 (es) Compuestos de tiazolo-piridina sustituida como inhibidores de malt1